Research Article
Neutropenia Prediction Based on First-Cycle Blood Counts Using a FOS-3NN Classifier
Table 1
(a) shows characteristics of the patient population. (b) shows treatment characteristics.
(a) |
| Group | Median age at first chemotherapy treatment |
| Training set | 46.79 | Testing set | 44.8 | Validation set | 56.19 | Entire population | 46.34 |
| Group | BMI at first chemotherapy treatment |
| Training set | 24.29 | Testing set | 25.7 | Validation set | 25.86 | Entire population | 25.71 |
|
|
(b) |
| | Training set | Testing set | Validation set | Entire patient population | | | | | |
| Radiation | | | | | Concurrent | 9 (64.3%) | 0 (0%) | 0 (0%) | 9 (25.7%) | Chemotherapy | | | | | CEF | 0 (0%) | 12 (85.7%) | 2 (28.6%) | 14 (40%) | CAF | 0 (0%) | 1 (7.1%) | 5 (71.4%) | 6 (17.1%) | CMF | 14 (100%) | 1 (7.1%) | 0 (0%) | 15 (42.9%) | Risk | | | | | High | 7 (50%) | 7 (50%) | 4 (57.1%) | 18 (51.4%) | low | 7 (50%) | 7 (50%) | 3 (42.9%) | 17 (48.6%) |
|
|
*Note that percentages may not add to 100% due to rounding.
|